Angiogenesis-dependent diseases

被引：190

作者：

Folkman, J

机构：

[1] Harvard Univ, Sch Med, Childrens Hosp, Dept Surg, Boston, MA 02115 USA

[2] Childrens Hosp, Surg Res Lab, Dept Surg, Boston, MA 02115 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期

关键词：

D O I：

10.1053/sonc.2001.29543

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：536 / 542

页数：7

共 42 条

[1] Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia [J].

Aguayo, A ;

Estey, E ;

Kantarjian, H ;

Mansouri, T ;

Gidel, C ;

Keating, M ;

Giles, F ;

Estrov, Z ;

Barlogie, B ;

Albitar, M .

BLOOD, 1999, 94 (11) :3717-3721

[2] Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers [J].

Bertolini, F ;

Mingrone, W ;

Alietti, A ;

Ferrucci, PF ;

Cocorocchio, E ;

Peccatori, F ;

Cineri, S ;

Mancuso, P ;

Corsini, C ;

Burlini, A ;

Zucca, E ;

Martinelli, G .

ANNALS OF ONCOLOGY, 2001, 12 (07) :987-990

[3]

Browder T, 2000, CANCER RES, V60, P1878

[4]

BRUNNER G, 1993, BLOOD, V81, P631

[5] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[6]

Folkman J, 2001, THROMB HAEMOSTASIS, V86, P23

[7]

FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182

[8]

FOLKMAN J, 2000, CANC MED, P132

[9]

Folkman J., 1997, CLIN APPL INTERFERON, P255

[10]

Folkman J., 2001, HARRISONS PRINCIPLES, V15th ed., P517

← 1 2 3 4 5 →